PortfoliosLab logoPortfoliosLab logo
TEVA vs. SHG
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TEVA vs. SHG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Teva Pharmaceutical Industries Limited (TEVA) and Shinhan Financial Group Co., Ltd. (SHG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TEVA achieves a 6.57% return, which is significantly lower than SHG's 19.17% return. Over the past 10 years, TEVA has underperformed SHG with an annualized return of -4.15%, while SHG has yielded a comparatively higher 9.12% annualized return.


TEVA

1D
-2.72%
1M
-6.91%
YTD
6.57%
6M
17.40%
1Y
87.17%
3Y*
65.55%
5Y*
25.39%
10Y*
-4.15%

SHG

1D
-4.85%
1M
-6.76%
YTD
19.17%
6M
19.73%
1Y
50.24%
3Y*
37.29%
5Y*
15.51%
10Y*
9.12%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TEVA vs. SHG - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TEVA
Teva Pharmaceutical Industries Limited
6.57%41.61%111.11%14.47%13.86%-16.99%-1.53%-36.45%-18.63%-46.18%
SHG
Shinhan Financial Group Co., Ltd.
19.17%68.28%12.80%15.25%-4.61%5.27%-21.83%7.27%-23.51%23.27%

Correlation

The correlation between TEVA and SHG is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (5Y)
Calculated over the trailing 5-year period

0.27

Correlation (10Y)
Calculated over the trailing 10-year period

0.23

Correlation (All Time)
Calculated using the full available price history since Sep 17, 2003

0.22

Fundamentals

Market Cap

TEVA:

$39.21B

SHG:

$30.83B

EPS

TEVA:

$1.34

SHG:

$10.58K

PE Ratio

TEVA:

24.87

SHG:

0.01

PEG Ratio

TEVA:

0.19

SHG:

0.00

PS Ratio

TEVA:

2.24

SHG:

0.00

PB Ratio

TEVA:

4.76

SHG:

0.00

Total Revenue (TTM)

TEVA:

$17.35B

SHG:

$34.80T

Gross Profit (TTM)

TEVA:

$9.03B

SHG:

$16.62T

EBITDA (TTM)

TEVA:

$3.05B

SHG:

$8.32T

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TEVA vs. SHG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TEVA
TEVA Risk / Return Rank: 9090
Overall Rank
TEVA Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
TEVA Sortino Ratio Rank: 9292
Sortino Ratio Rank
TEVA Omega Ratio Rank: 9191
Omega Ratio Rank
TEVA Calmar Ratio Rank: 8989
Calmar Ratio Rank
TEVA Martin Ratio Rank: 8989
Martin Ratio Rank

SHG
SHG Risk / Return Rank: 8282
Overall Rank
SHG Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
SHG Sortino Ratio Rank: 8282
Sortino Ratio Rank
SHG Omega Ratio Rank: 7878
Omega Ratio Rank
SHG Calmar Ratio Rank: 8282
Calmar Ratio Rank
SHG Martin Ratio Rank: 8484
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TEVA vs. SHG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Teva Pharmaceutical Industries Limited (TEVA) and Shinhan Financial Group Co., Ltd. (SHG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


TEVASHGDifference
Sharpe ratioReturn per unit of total volatility

+0.59

Sortino ratioReturn per unit of downside risk

+1.01

Omega ratioGain probability vs. loss probability

1.43

1.28

+0.15

Calmar ratioReturn relative to maximum drawdown

4.02

2.80

+1.22

Martin ratioReturn relative to average drawdown

10.94

7.79

+3.14

TEVA vs. SHG - Sharpe Ratio Comparison

The current TEVA Sharpe Ratio is 2.25, which is higher than the SHG Sharpe Ratio of 1.67. The chart below compares the historical Sharpe Ratios of TEVA and SHG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


TEVASHGDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.25

1.67

+0.59

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.59

0.52

+0.07

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.09

0.30

-0.39

Sharpe Ratio (All Time)

Calculated using the full available price history

0.31

0.23

+0.09

Drawdowns

TEVA vs. SHG - Drawdown Comparison

The maximum TEVA drawdown since its inception was -90.89%, which is greater than SHG's maximum drawdown of -82.02%. Use the drawdown chart below to compare losses from any high point for TEVA and SHG.


Loading charts...

Drawdown Indicators


TEVASHGDifference

Max Drawdown

Largest peak-to-trough decline

-90.89%

-82.02%

-8.87%

Max Drawdown (1Y)

Largest decline over 1 year

-21.79%

-18.03%

-3.76%

Max Drawdown (3Y)

Largest decline over 3 years

-43.70%

-35.19%

-8.51%

Max Drawdown (5Y)

Largest decline over 5 years

-43.70%

-37.00%

-6.70%

Max Drawdown (10Y)

Largest decline over 10 years

-88.41%

-65.50%

-22.91%

Current Drawdown

Current decline from peak

-50.84%

-10.89%

-39.95%

Average Drawdown

Average peak-to-trough decline

-32.00%

-33.84%

+1.84%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.00%

6.47%

+1.53%

Volatility

TEVA vs. SHG - Volatility Comparison

Teva Pharmaceutical Industries Limited (TEVA) and Shinhan Financial Group Co., Ltd. (SHG) have volatilities of 9.18% and 9.51%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TEVASHGDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.18%

9.51%

-0.33%

Volatility (6M)

Calculated over the trailing 6-month period

23.54%

22.62%

+0.92%

Volatility (1Y)

Calculated over the trailing 1-year period

38.97%

30.37%

+8.60%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

42.94%

29.92%

+13.02%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

47.34%

30.32%

+17.02%

Dividends

TEVA vs. SHG - Dividend Comparison

TEVA has not paid dividends to shareholders, while SHG's dividend yield for the trailing twelve months is around 0.64%.


PositionTTM20252024202320222021202020192018201720162015
SHG
Shinhan Financial Group Co., Ltd.
0.64%2.24%5.96%3.87%5.54%1.54%0.00%0.00%0.00%0.00%3.35%3.10%
TEVA
Teva Pharmaceutical Industries Limited
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%3.88%3.19%1.77%

Financials

TEVA vs. SHG - Financials Comparison

This section allows you to compare key financial metrics between Teva Pharmaceutical Industries Limited and Shinhan Financial Group Co., Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00T4.00T6.00T8.00T10.00T20222023202420252026
3.98B
8.73T
(TEVA) Total Revenue
(SHG) Total Revenue
Values in USD except per share items

TEVA vs. SHG - Profitability Comparison

The chart below illustrates the profitability comparison between Teva Pharmaceutical Industries Limited and Shinhan Financial Group Co., Ltd. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%20222023202420252026
49.5%
48.0%
Portfolio components
TEVA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a gross profit of 1.97B and revenue of 3.98B. Therefore, the gross margin over that period was 49.5%.

SHG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Shinhan Financial Group Co., Ltd. reported a gross profit of 4.19T and revenue of 8.73T. Therefore, the gross margin over that period was 48.0%.

TEVA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported an operating income of 652.00M and revenue of 3.98B, resulting in an operating margin of 16.4%.

SHG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Shinhan Financial Group Co., Ltd. reported an operating income of 2.29T and revenue of 8.73T, resulting in an operating margin of 26.2%.

TEVA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a net income of 369.00M and revenue of 3.98B, resulting in a net margin of 9.3%.

SHG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Shinhan Financial Group Co., Ltd. reported a net income of 1.62T and revenue of 8.73T, resulting in a net margin of 18.6%.


Frequently Asked Questions


TEVA and SHG have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SHG has higher volatility (9.51%) compared to TEVA (9.18%). In terms of maximum drawdown, TEVA dropped -90.89% vs SHG's -82.02%.

TEVA currently has the higher Sharpe Ratio (2.25 vs 1.67), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TEVA and SHG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer